Regulatory Q&A Forum

When preparing a 510(k) submission, what are the critical process steps and documentation requirements a sponsor must manage to ensure the correct MDUFA user fee is paid, thereby avoiding a Refuse to ...

For a small medical device company planning its first 510(k) submission, what are the critical steps and strategic considerations for successfully qualifying for a reduced MDUFA user fee through the S...

With the mandatory transition to eSTAR for 510(k) submissions, sponsors of Class II devices, such as novel diagnostic imaging software or connected surgical instruments, are re-evaluating their go-to-...

When a medical device sponsor develops a product with novel technological characteristics but an intended use identical to legally marketed devices, what is the strategic framework for determining if ...

While the FDA's MDUFA performance goal for reviewing a 510(k) submission is 90 calendar days, the total time from submission to clearance often extends significantly longer. For sponsors planning a pr...

For a sponsor developing a 510(k) for a Class II implantable device, such as a PEEK spinal cage or a titanium bone screw with permanent tissue contact, what constitutes a robust, risk-based biocompati...

When a manufacturer modifies a previously cleared 510(k) device—for example, updating an infusion pump with a new motor and software incorporating enhanced cybersecurity features—while keeping the int...

For a small medical device company preparing a 510(k) submission, successfully qualifying for the reduced MDUFA user fee is a critical financial planning step. Beyond simply identifying the fee on the...

When preparing a 510(k) for a Class II medical device, particularly one with significant software or cybersecurity elements like a connected infusion pump or diagnostic SaMD, what are the most critica...

The FDA’s 90-day performance goal for 510(k) review is a widely cited metric, but it represents 'FDA Days,' not calendar days, a distinction that significantly impacts project timelines. For a Class I...

For a Class II device with patient-contacting components intended for a 510(k) submission, what constitutes a robust and defensible biocompatibility evaluation strategy that anticipates common FDA que...

When preparing a 510(k) for a device that has different technological characteristics from its predicate—such as a novel material, a different energy source, or a new software algorithm—how can sponso...

When a medical device manufacturer develops a new device that combines features from multiple legally marketed devices—for example, a new catheter incorporating an advanced sensor from Predicate A and...

When developing a 510(k) submission for a device incorporating novel features, such as an electrosurgical device with a new tissue-sensing feedback algorithm, what is the most effective analytical fra...

While the FDA's MDUFA performance goal for a 510(k) submission is a standard benchmark, experienced sponsors know that the "total time to clearance" often extends beyond this target due to holds and r...

When building a financial plan for a new Class II medical device, such as a novel surgical instrument or a software platform, how should a sponsor strategically navigate the mandatory FDA 510(k) user ...

For medical device companies preparing a 510(k) submission, what are the key procedural considerations for correctly identifying and paying the appropriate Medical Device User Fee Amendments (MDUFA) f...

When preparing a 510(k) submission for a modern medical device, such as a connected infusion pump or a diagnostic Software as a Medical Device (SaMD), a manufacturer might select a predicate device th...

When a manufacturer modifies a 510(k)-cleared device, such as updating the software or changing a material component in an infusion pump, what is the detailed analytical framework for deciding between...

When a medical device manufacturer, particularly a startup, develops a budget for a 510(k) submission, how can they accurately forecast the total investment beyond the publicly listed FDA user fees? S...